NVIDIA
NVDA
Tesla
TSLA
Palantir
PLTR
4
BigBear.ai Holdings
BBAI
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
BRTX Biorestorative Therapies
- 1.520
- -0.100-6.17%
Close Feb 28 16:00 ET
- 1.510
- -0.010-0.66%
Post 19:55 ET
10.52MMarket Cap-1.06P/E (TTM)
1.600High1.430Low321.58KVolume1.550Open1.620Pre Close489.34KTurnover7.42%Turnover RatioLossP/E (Static)6.92MShares2.55052wk High1.05P/B6.59MFloat Cap1.03052wk Low--Dividend TTM4.34MShs Float8.900Historical High--Div YieldTTM10.49%Amplitude1.030Historical Low1.521Avg Price1Lot Size
Biorestorative Therapies Stock Forum
BioRestorative's FDA clearance for their BRTX-100 IND in chronic cervical discogenic pain represents a significant clinical and strategic expansion that could substantially enhance the company's market position in regenerative medicine for spinal conditions.
This development is particularly noteworthy for three key reasons:
BRTX-100 becomes the first and only stem cell therapy cleared for evaluation in cervical degenerative disc disease, esta...
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
First-Ever Stem Cell Treatment for Neck Pain Gets FDA Green Light - What Makes BRTX-100 Revolutionary?
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
Thursday, 27th February at 9:45 am
– BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting –
– IND clearance expands Company's advanced clinical pipeline for BRTX-100 treatment of both chronic lower back and neck pain –
– Company to host webcasted conference call today...
They have conference call tomorrow 10:30 am est
BioRestorative Announces Updated Time for February 27th Webcasted Conference Call to Discuss Clinical Pipeline Update
Wednesday, 26th February at 8:15 pm
MELVILLE, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ: BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, announced today that it has changed the time for its previously ...
taking a starter position here
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY...
No comment yet